Standard Versus Limited Pelvic Lymph Node Dissection for Prostate Cancer in Patients With a Predicted Probability of Nodal Metastasis Greater Than 1%

Journal of Urology

Volumn 178, Issue 1, 2007, Pages 120-124

  Touijer, Karim ^a   Rabbani, Farhang ^a   Otero, Javier Romero ^a   Secin, Fernando P ^a   Eastham, James A ^a   Scardino, Peter T ^a   Guillonneau, Bertrand ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

laparoscopy; lymph node excision; nomograms; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEASIBILITY STUDY; GLEASON SCORE; HUMAN; HYPOGASTRIC NERVE; ILIAC VEIN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBTURATOR NERVE; PATHOLOGY; PELVIS LYMPHADENECTOMY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; PROSTATECTOMY; RISK; SURGICAL APPROACH;

HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; MULTIVARIATE ANALYSIS; NOMOGRAMS; PROSTATIC NEOPLASMS;

EID: 34250190640     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.018     Document Type: Article

References (20)

1. Bluestein D.L., Bostwick D.G., Bergstralh E.J., and Oesterling J.E. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151 (1994) 1315
2. Bishoff J.T., Reyes A., Thompson I.M., Harris M.J., St Clair S.R., Gomella L., et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 45 (1995) 270
3. McCullough D.L., Prout Jr. G.R., and Daly J.J. Carcinoma of the prostate and lymphatic metastases. J Urol 111 (1974) 65
4. McLaughlin A.P., Saltzstein S.L., McCullough D.L., and Gittes R.F. Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 115 (1976) 89
5. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849
6. Daneshmand S., Quek M.L., Stein J.P., Lieskovsky G., Cai J., Pinski J., et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172 (2004) 2252
7. Allaf M.E., Palapattu G.S., Trock B.J., Carter H.B., and Walsh P.C. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172 (2004) 1840
8. Partin A.W., Kattan M.W., Subong E.N., Walsh P.C., Wojno K.J., Oesterling J.E., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445
9. Zincke H. Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome. Urology 33 (1989) 27
10. Petros J.A., and Catalona W.J. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol 147 (1992) 1574
11. Han M., Partin A.W., Pound C.R., Epstein J.I., and Walsh P.C. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28 (2001) 555
12. Hinkle G.H., Burgers J.K., Neal C.E., Texter J.H., Kahn D., Williams R.D., et al. Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide. Cancer 83 (1998) 739
13. Flanigan R.C., McKay T.C., Olson M., Shankey T.V., Pyle J., and Waters W.B. Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 48 (1996) 428
14. Cagiannos I., Karakiewicz P., Eastham J.A., Ohori M., Rabbani F., Gerigk C., et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170 (2003) 1798
15. Guillonneau B., el-Fettouh H., Baumert H., Cathelineau X., Doublet J.D., Fromont G., et al. Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases at Montsouris Institute. J Urol 169 (2003) 1261
16. Stolzenburg J.U., Rabenalt R., Do M., Ho K., Dorschner W., Waldkirch E., et al. Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures. J Urol 174 (2005) 1271
17. Ferrari A.C., Stone N.N., Eyler J.N., Gao M., Mandeli J., Unger P., et al. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. J Natl Cancer Inst 89 (1997) 1498
18. Edelstein R.A., Zietman A.L., de las Morenas A., Krane R.J., Babayan R.K., Dallow K.C., et al. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology 47 (1996) 370
19. Cathelineau X., Cahill D., Widmer H., Rozet F., Baumert H., Vallancien G., et al. Transperitoneal or extraperitoneal approach for laparoscopic radical prostatectomy: a false debate over a real challenge. J Urol 171 (2004) 714
20. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491